BACK TO TOP
KSE100
168,787.88
-2791.42
(-1.63%)
KSE100PR
51,918.27
-939.75
(-1.78%)
ALLSHR
100,927.34
-1450.60
(-1.42%)
KSE30
51,100.68
-1004.45
(-1.93%)
KMI30
242,070.72
-4032.88
(-1.64%)
BKTI
47,489.19
-1173.76
(-2.41%)
OGTI
35,038.29
-726.40
(-2.03%)
KMIALLSHR
65,275.07
-961.95
(-1.45%)
PSXDIV20
77,871.51
-1083.88
(-1.37%)
UPP9
59,651.59
-953.06
(-1.57%)
NITPGI
44,892.05
-739.87
(-1.62%)
NBPPGI
49,064.44
-807.68
(-1.62%)
MZNPI
30,010.12
-461.65
(-1.52%)
JSMFI
41,419.75
-581.72
(-1.38%)
ACI
21,941.57
-523.59
(-2.33%)
JSGBKTI
72,235.02
-1532.07
(-2.08%)
HBLTTI
18,276.77
22-04-2026
5.93
(0.03%)
MII30
21,821.66
-355.89
(-1.60%)
Abbott Laboratories (Pakistan) Limited
XD
PHARMACEUTICALS
Rs.929.00
-16.39
(-1.73%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Apr 23, 2026 2:14 PM
REG
DFC
CSF
ODL
Open
881.00
High
950.00
Low
881.00
Volume
9,123
CIRCUIT BREAKER
850.85 — 1,039.93
DAY RANGE
881.00 — 950.00
52-WEEK RANGE ^
790.00 — 1,304.00
Ask Price
929.00
Ask Volume
138
Bid Price
925.02
Bid Volume
8
LDCP
945.39
VAR
12.50
HAIRCUT
25.00
P/E Ratio (TTM) **
11.42
1-Year Change * ^
-12.27%
YTD Change * ^
-11.54%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Syed Anis AhmedCEO
Ehsan A. MalikChairperson
Muhammad Usama JamilCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Share Registration Services (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
90,949,380.56
Shares
97,900,302
Free Float
21,150,394
Free Float
21.60%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 8, 2026Transmission of Annual Report for the Year Ended December 31, 2025 View   PDF
Mar 16, 2026Financial Results for the Year Ended December 31, 2025 View   PDF
Oct 30, 2025Transmission of Quarterly Reports for the Period Ended September 30, 2025 View   PDF
Oct 29, 2025Financial Results for the Quarter Ended September 30, 2025 View   PDF
Aug 29, 2025Transmission of Quarterly Account for the Period Ended June 30, 2025 View   PDF
DateTitleDocument
Apr 20, 2026Board Meeting View   PDF
Apr 8, 2026Notice of Annual General Meeting View   PDF
Apr 1, 2026Change in Date and Time of the 77th Annual General Meeting View   PDF
Mar 9, 2026Board Meeting View   PDF
Oct 22, 2025Board Meeting View   PDF
DateTitleDocument
Dec 30, 2025ABOT | Abbott Laboratories (Pakistan) Limited Revised Presentation of Corporate Briefing Session 2025
REVISED
PDF
Dec 30, 2025ABOT | Abbott Laboratories (Pakistan) Limited Corporate Briefing Session (CBS)
REVOKED
PDF
Dec 29, 2025Presentation of Corporate Briefing Session 2025 View   PDF
Dec 26, 2025Corporate Briefing Session 2025 View   PDF
Nov 25, 2025Appointment of Director View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales75,397,73268,177,19755,475,27049,257,722
Profit after Taxation7,966,5005,234,233261,7773,004,186
EPS81.3753.462.6730.69
Q3 2025Q2 2025Q1 2025Q3 2024
Sales19,819,13419,061,33817,346,45117,364,546
Profit after Taxation1,822,5461,943,4991,599,6731,809,143
EPS18.6219.8516.3418.48
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)35.0828.9521.3629.49
Net Profit Margin (%)10.577.680.476.10
EPS Growth (%)52.211,902.25(91.30)(49.65)
PEG0.250.01(1.89)(0.30)

Payouts

Financial Reports